Biological Signatures of Alzheimer’s Disease
Journal:
Current Topics in Medicinal Chemistry
Volume:
20
Page:
770-781
Author(s):
Poornima Sharma, Anjali Sharma, Faizana Fayaz, Sharad Wakode* and Faheem H. Pottoo
Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Journal:
Current Alzheimer Research
Volume:
17
Page:
224-237
Author(s):
Adrianna Wysocka, Ewelina Palasz, Marta Steczkowska and Grazyna Niewiadomska*
Recent Advancement in Computer-Aided Drug Design
Journal:
Current Pharmaceutical Design
Volume:
26
Page:
1635-1636
Author(s):
Luciana Scotti and Marcus Tullius Scotti
Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory Deficits
Journal:
Current Pharmaceutical Design
Volume:
26
Page:
1693-1711
Author(s):
Alaa Alachkar, Shreesh K. Ojha, Adel Sadeq, Abdu Adem, Annika Frank, Holger Stark and Bassem Sadek*
Aquaporins and Roles in Brain Health and Brain Injury
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
20
Page:
498-512
Author(s):
Dervis Dasdelen, Rasim Mogulkoc* and Abdülkerim Kasim Baltaci
Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders
Journal:
Current Pharmaceutical Design
Volume:
26
Page:
1277-1285
Author(s):
Cecilia Maldonado *, Marta Vázquez and Pietro Fagiolino
Magnolia officinalis Reduces Inflammation and Damage Induced by Recurrent Status Epilepticus in Immature Rats
Journal:
Current Pharmaceutical Design
Volume:
26
Page:
1388-1401
Author(s):
Angélica Vega-García , Luisa Rocha, Rosalinda Guevara-Guzmán , Christian Guerra-Araiza , Iris Feria-Romero, Juan M. Gallardo, Teresa Neri-Gomez, José E. Suárez-Santiago and Sandra Orozco-Suarez*
Neuroprotective and Neurorestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases
Journal:
Current Pharmaceutical Design
Volume:
26
Page:
1263-1276
Author(s):
Mónica E. Ureña-Guerrero*, José L. Castañeda-Cabral, Martha C. Rivera-Cervantes, Rafael J. Macias-Velez, José J. Jarero-Basulto, Graciela Gudiño-Cabrera and Carlos Beas-Zárate
EPO and EPO-Receptor System as Potential Actionable Mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP
Journal:
Current Pharmaceutical Design
Volume:
26
Page:
1356-1364
Author(s):
Jerónimo Auzmendi , María B. Puchulu, Julio C. G. Rodríguez , Ana M. Balaszczuk , Alberto Lazarowski and Amalia Merelli *
Investigation of the Roles of New Antiepileptic Drugs and Serum BDNF Levels in Efficacy and Safety Monitoring and Quality of Life: A Clinical Research
Journal:
Current Clinical Pharmacology
Volume:
15
Page:
49-63
Author(s):
Meral Demir*, Emel O. Akarsu, Hava O. Dede, Nerses Bebek, Sevda O. Yıldız, Betül Baykan and Ahmet G. Akkan